No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Humanized* / adverse effects
-
Humans
-
Neoplasms* / drug therapy
Substances
-
Antibodies, Monoclonal, Humanized
-
camrelizumab
Associated data
-
ClinicalTrials.gov/NCT02721589